---
title: "Bandaram Pharma Packtech Ltd (524602) — Share Price, Financials & Analysis"
symbol: "524602"
company: "Bandaram Pharma Packtech Ltd"
canonical: "https://tapetide.com/stocks/524602"
isin: "INE875N01036"
nse_symbol: "BANDARAMPHARMAPACKTECHLTD"
bse_code: "524602"
sector: "Healthcare Services"
industry: "Healthcare Service Provider"
market_cap_cr: 38.6
generated_at: "2026-09-13T19:16:41.272Z"
---

# Bandaram Pharma Packtech Ltd (524602)

Canonical page: https://tapetide.com/stocks/524602

## Company

- **NSE Symbol:** BANDARAMPHARMAPACKTECHLTD
- **BSE Code:** 524602
- **ISIN:** INE875N01036
- **Sector:** Healthcare Services
- **Industry:** Healthcare Service Provider
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2022-12-22
- **CEO:** Mr. Bandaram Deepak Reddy
- **Employees:** 21
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bandaram.com

## About

Incorporated in 2022, Bandaram Pharma Packtech Ltd deals in procurement and supply of recycled paper[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:42:40.353212Z.

- **Market Cap:** ₹38.6 Cr
- **Classification:** Microcap
- **P/E (reported):** 32.6
- **EPS (TTM):** ₹0.56
- **EPS (reported):** ₹0.86
- **Book Value:** ₹14.9
- **Price to Book:** 1.44
- **Dividend Yield:** 0.47%
- **ROE:** 6.28%
- **ROCE:** 9.25%
- **Debt to Equity:** 0.89
- **Revenue (yearly):** ₹62.92 Cr
- **Net Income:** ₹0.44 Cr
- **EBITDA:** ₹2.9 Cr
- **52-Week High:** ₹49.7
- **52-Week Low:** ₹17.25
- **RSI (14):** 57.38

## Tapetide Score

- **Score:** 39 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 12 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 23.8 | 9% |
| growth | 98.9 | 9% |
| momentum | 14.09 | 12% |
| ownership | 50 | 24% |
| quality | 26.91 | 22% |
| valuation | 35.98 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter

### Weaknesses

- Company has a low return on equity of 6.00% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 182 days.
- Promoter holding has decreased over last 3 years: -12.3%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -19.37% | -348.18% | -114.11% |
| ebitda margin growth | 87.5% | -41.42% | -44.86% | — |
| net income growth | 600% | -56% | 48% | — |
| revenue growth | -8.75% | 69.6% | 50% | — |
| roce | 131.03% | -13.55% | 56.51% | — |
| roe | 655.56% | -0.16% | 5.86% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7.36 | 7.36 | 13.43 | 11.37 | 7.11 | 10 | 8.49 | 8.1 | 13.72 | 14.84 | 26.26 | 23.95 |
| Expenses | 6.89 | 6.89 | 12.7 | 10.83 | 6.02 | 9.34 | 7.95 | 7.47 | 13.27 | 13.84 | 25.44 | 22.4 |
| Operating Profit | 0.47 | 0.47 | 0.73 | 0.54 | 1.09 | 0.66 | 0.54 | 0.63 | 0.45 | 1 | 0.82 | 1.55 |
| OPM % | 6.39 | 6.39 | 5.44 | 4.75 | 15.33 | 6.6 | 6.36 | 7.78 | 3.28 | 6.74 | 3.12 | 6.47 |
| Other Income | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.09 | 0 | 0.01 | 0 | 0.01 | 0 |
| Interest | 0.17 | 0.17 | 0.32 | 0.21 | 0.26 | 0.24 | -0.1 | 0.46 | 0.25 | 0.33 | 0.46 | 0.42 |
| Depreciation | 0.18 | 0.18 | 0.19 | 0.15 | 0.15 | 0.15 | 0.53 | 0.13 | 0.14 | 0.14 | 0.25 | 0.2 |
| Profit before tax | 0.12 | 0.12 | 0.25 | 0.18 | 0.68 | 0.27 | 0.2 | 0.04 | 0.07 | 0.53 | 0.12 | 0.93 |
| Tax % | 0 | 0 | 24 | 0 | 0 | 103.7 | 25 | 25 | 28.57 | 33.96 | 25 | 25.81 |
| Net Profit | 0.12 | 0.12 | 0.19 | 0.18 | 0.67 | -0.02 | 0.15 | 0.02 | 0.06 | 0.35 | 0.09 | 0.68 |
| EPS in Rs | 0.1 | 0.1 | 0.16 | 0.15 | 0.56 | -0.01 | 0.12 | 0.02 | 0.02 | 0.11 | 0.05 | 0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 18.73 | 34.08 | 36.96 | 62.92 | 78.77 |
| Expenses | 0.01 | 17.58 | 31.26 | 34.13 | 60.02 | 74.95 |
| Operating Profit | -0.01 | 1.15 | 2.82 | 2.83 | 2.9 | 3.82 |
| OPM % | — | 6.14 | 8.27 | 7.66 | 4.61 | 4.85 |
| Other Income | 0 | 0.19 | 0.03 | 0.09 | 0.02 | 0.02 |
| Interest | 0 | 0.43 | 0.93 | 0.99 | 1.51 | 1.46 |
| Depreciation | 0 | 0.59 | 0.73 | 0.61 | 0.97 | 0.73 |
| Profit before tax | -0.01 | 0.32 | 1.19 | 1.32 | 0.44 | 1.65 |
| Tax % | 0 | 21.88 | 20.17 | 24.24 | -2.27 | — |
| Net Profit | -0.01 | 0.26 | 0.95 | 0.99 | 0.45 | 1.18 |
| EPS in Rs | -0.01 | 0.12 | 0.79 | 0.82 | 0.25 | 0.56 |
| Dividend Payout % | 0 | 21.43 | 12.63 | 12.12 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 7.06 | 3 | 12 | 12 | 17.97 |
| Reserves | -0.06 | 0.08 | 0.28 | 0.65 | 8.81 |
| Borrowings | 0 | 14.2 | 12.2 | 17.15 | 23.94 |
| Other Liabilities | 0.48 | 2.9 | 7.58 | 9.12 | 25.14 |
| Total Liabilities | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |
| Fixed Assets | 2.87 | 5.03 | 4.48 | 3.95 | 15.22 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 2.09 | 0 | 1.4 | 1.4 | 0 |
| Other Assets | 2.52 | 15.15 | 26.18 | 33.57 | 60.64 |
| Total Assets | 7.48 | 20.18 | 32.06 | 38.92 | 75.86 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -1.1 | -4.13 | -4.93 | -4.92 |
| Cash from Investing Activity | — | -5.3 | -1.58 | -0.08 | 0 |
| Cash from Financing Activity | — | 4.47 | 5.59 | 5.09 | 5.53 |
| Net Cash Flow | — | -1.93 | -0.11 | 0.08 | 0.6 |
| Free Cash Flow | — | -3.89 | -4.31 | -5.01 | -4.92 |
| CFO/OP | — | -96 | -139 | -163 | -170 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 129.01 | 155.51 | 185.27 | 181.86 |
| Inventory Days | — | — | — | — | 87.71 |
| Days Payable | — | — | — | — | 110.21 |
| Cash Conversion Cycle | — | 129.01 | 155.51 | 185.27 | 159.36 |
| Working Capital Days | — | 147.13 | 147.59 | 165.22 | 127.27 |
| ROCE % | — | 5.69 | 9.1 | 7.67 | 4.42 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 75% | 62.62% | 62.66% | 62.66% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 24.38% | 24.11% | 24.21% | 24.23% | 23.99% | 23.73% | 23.74% | 23.74% | 23.75% | 36.27% | 36.22% | 36.2% |
| Others | 0.61% | 0.88% | 0.78% | 0.76% | 1% | 1.26% | 1.25% | 1.25% | 1.25% | 1.11% | 1.11% | 1.13% |
| No. of Shareholders | 4273 | 4262 | 4337 | 4425 | 4634 | 4767 | 4827 | 4889 | 4955 | 5095 | 5078 | 5103 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 6 / 5

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 20.87 | Buy |
| EMA (10) | 20.81 | Buy |
| SMA (20) | 19.44 | Buy |
| EMA (20) | 20.3 | Buy |
| SMA (50) | 20.7 | Buy |
| EMA (50) | 21.27 | Sell |
| SMA (100) | 24.37 | Sell |
| EMA (100) | 23.33 | Sell |
| SMA (200) | 26.76 | Sell |
| EMA (200) | 26.58 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.87 | Neutral |
| MACD (12,26,9) | 0.31 | Buy |
| Stochastic (14,3,3) | 63.95 | Neutral |
| ADX (14) | 31.32 | Buy |
| Williams %R (14) | -40.48 | Neutral |
| ATR (14) | 1.61 | High Volatility |
| ROC (12) | 12.8 | Buy |
| Stoch RSI (14) | 67.74 | Neutral |
| UO (7,14,28) | 39.11 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Notice Of AGM For The FY 2025-26 Scheduled To Be Held On 24.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97bca7c9-b918-4b07-8e56-4635fa1e2ca5.pdf) |
| 2026-09-01 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73fb9268-9e9a-4886-bd54-e66bb71068f1.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f2141b4-d536-491e-8734-69d00f112e6a.pdf) |
| 2026-08-06 | [Board Meeting Intimation for Board Meeting To Be Held On 13.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f742a8cf-38d5-4f5e-82da-6ea16ff13696.pdf) |
| 2026-07-11 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6f03704-8b10-4434-9fde-f9fde357c26c.pdf) |
| 2026-07-07 | [Clarification Of Price Movement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61a907d3-dfd7-4a71-83e2-219b7b6514c0.pdf) |
| 2026-06-24 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fe03ade-a4d3-46b5-99a4-ab509b98e560.pdf) |
| 2026-06-11 | [Receipt Of Order](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f597cc87-b1a5-49fe-a5d1-4d9c1493fab5.pdf) |
| 2026-06-05 | [Announcement under Regulation 30 (LODR)-Resignation of Director](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f8b2ae6-f2df-4354-ad96-37c2db432c2e.pdf) |
| 2026-05-30 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03304e8e-cfc8-42c5-8991-3e8b06916119.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Un-Audited Financial Results (Standalone & Consolidated) For The Quater Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6092e62a-87ff-4aa0-a5aa-b1f8c3366835.pdf) |
| 2026-05-30 | [Audited Financial Results For The Quarter And Year Ended 31.03.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=011f22b2-ee03-4734-a612-15c0403c3b31.pdf) |
| 2026-02-13 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42ea41ca-4e25-44da-8bd6-76f1fbff4912.pdf) |
| 2025-11-13 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14cbf23f-ef9c-423b-91d3-f1fb23740269.pdf) |
| 2025-08-14 | [Un-Audited Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62b3ea22-49dd-42bf-9648-d5ce765d76fd.pdf) |
| 2025-05-30 | [Results For Financial Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbc684a2-e65a-4433-8c72-dca66eb12bfc.pdf) |
| 2024-08-13 | [Results (Standalone And Consolidated) For The Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=803c682d-266d-4e54-ad4c-86f193104248.pdf) |
| 2024-05-29 | [Audited Financial Results For The Quarter Ended 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa054831-ba8f-4baf-bc3c-b40eca1b3791.pdf) |
| 2024-02-12 | [Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 31.12.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2537843-88c7-44c9-b14d-28961e00004a.pdf) |
| 2024-02-01 | [Revised Results For The Quarter And Half Year Ended 30.09.23](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b63ca3e6-a02f-4a3f-8243-c46ce719668f.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 30 Jan - Appointed Eswar Reddy Putturu as Independent Director (5-year term); Priyanka Agarwal resigned, effective 30.01.2026. | [Board Meeting Outcome for Outcome Of Board Meeting Held On 30.01.2026 30 Jan - Appointed Eswar Reddy Putturu as Independent Director (5-year term); Priyanka Agarwal resigned, effective 30.01.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40fcc79c-ab9e-422a-b621-a4ade3c83cda.pdf) |
| 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d1b80d05-ea8f-4a4b-adb0-f6560ce20965.pdf) |
| 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Bandaram Pharma Packtech says it is not a large corporate; FY2026-27 initial disclosure not applicable.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d1b80d05-ea8f-4a4b-adb0-f6560ce20965.pdf) |
| 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30cdf98a-049c-45e8-a14f-0cff0a8f9799.pdf) |
| 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Bandaram Pharma Packtech confirms it is not a Large Corporate for FY2025-26; no debt borrowing reported.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/30cdf98a-049c-45e8-a14f-0cff0a8f9799.pdf) |
| 3 Feb - Board meeting on 13-Feb-2026 to consider unaudited Q3 and nine-month results ended 31-Dec-2025. | [Board Meeting Intimation for Meeting To Be Held On 13-02-2026. 3 Feb - Board meeting on 13-Feb-2026 to consider unaudited Q3 and nine-month results ended 31-Dec-2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53516f7d-d5c5-425d-8fd5-487ec128e294.pdf) |
| 3 Apr - Board approved material RPTs with subsidiary VSR Paper and Packaging; EGM on 27.04.2026 for approvals. | [Board Meeting Outcome for Outcome Of Board Meeting To Be Held On 03.04.2026 3 Apr - Board approved material RPTs with subsidiary VSR Paper and Packaging; EGM on 27.04.2026 for approvals.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bc9e4dc2-4f65-4804-99fc-055dc3af9d2b.pdf) |
| 27 Mar - Trading window closed 01.04.2026 until 48 hours after FY2026 audited results; Board meeting to approve results. | [Closure of Trading Window 27 Mar - Trading window closed 01.04.2026 until 48 hours after FY2026 audited results; Board meeting to approve results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7ceb3006-712d-4afe-8934-19f13a73186e.pdf) |
| 27 Apr - Scrutinizer report for 1st EGM on 27 April 2026; all three resolutions passed. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 27 Apr - Scrutinizer report for 1st EGM on 27 April 2026; all three resolutions passed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47ada86f-2af3-4684-b105-2a105dcacff9.pdf) |
| 27 Apr - Bandaram Pharma Packtech’s 1st EGM on 27 Apr 2026 passed three resolutions, including an independent director appointment and related-party transactions. | [Shareholder Meeting / Postal Ballot-Outcome of EGM 27 Apr - Bandaram Pharma Packtech’s 1st EGM on 27 Apr 2026 passed three resolutions, including an independent director appointment and related-party transactions.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c832b41-6a91-4e00-96f1-a3087d009afe.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/175a3e4f-1670-42f7-b451-2f6ff19cd794.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b5b9132-3d4e-4c3f-940f-5d3019b0dd7b.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/19d018ad-952a-4f95-be22-4d22ba62e3b8.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/76742524602.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020317.pdf) |
| from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020316.pdf) |
| from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020315.pdf) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/524602/5246020313.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:41.272Z.